Breast cancer drug may have serious risk

The hormone drug Tamoxifen is a standard treatment for estrogen receptive breast cancer, but a new study links long-term use of the drug to a rare and aggressive second form of breast cancer.

• More: Most Popular stories, videos and more
• More: Get breaking news alerts

Experts say the findings shouldn't stop breast cancer patients from taking Tamoxifen because of its proven benefits.

However, patients should be aware of the potential risks.

Report Typo |  Send Tip |  Get Alerts | Most Popular
Follow @abc7 on Twitter  |  Become a fan on Facebook